Epigenetics and stem cell reprogramming

Induced pluripotent stem cells (iPSCs) are somatic cells reprogrammed into an embryonic-like pluripotent state by the expression of specific transcription factors. Despite the fact that these cells have the capacity to self-renew, they present low efficiency of reprogramming Recent studies have demonstrated that the previous somatic epigenetic signature is a limiting factor in iPSC performance.

 

  • Somatic cell nuclear transfer
  • Programming by cell fusion

Related Conference of Epigenetics and stem cell reprogramming

February 25-26, 2021

5th Global summit on Cancer Science and Oncology

Vienna, Austria
February 25-26, 2021

20th Global Summit on Breast Cancer

Amsterdam, Netherlands
April 05-06, 2021

2 nd Global Summit on Oncology and Hematology

Berlin, Germany
April 28-29, 2021

11th World Congress on Breast Cancer

Barcelona, Spain
May 17-18, 2021

8th World Congress on Epigenetics and Chromosome

Zurich, Switzerland
May 17-18, 2021

11th World Congress on Breast Cancer & Therapies

Prague, Czech Republic
June 23-24, 2021

41st Euro Congress on Cancer Science & Therapy

Barcelona, Spain
July 12-13, 2021

World Congress on Women Oncology & Care

Melbourne, Australia
July 12-13, 2021

Global Immuno-Oncology & Biomarkers Summit

Melbourne, Australia
July 29-30, 2021

5th Global Summit on Cancer and Oncology Research

Vienna, Austria
August 13-14, 2021

2nd World Cancer, Oncology and Therapeutics Congress

Munich, Germany
August 22-23, 2021

40th World Cancer Conference

Vienna, Austria
September 20-21, 2021

42nd Annual Summit on Oncology and Cancer

Singapore, Singapore
October 07-08, 2021

19th Asia Pacific Oncologists Annual Meeting

London, Aland Islands

Epigenetics and stem cell reprogramming Conference Speakers

Recommended Sessions

Related Journals

Are you interested in